Anthralin stimulates keratinocyte-derived proinflammatory cytokines via generation of reactive oxygen species

Inflammation Research

Volumn 47, Issue 4, 1998, Pages 174-181

  Lange, R W ^a,b,d   Hayden, P J ^a,e   Chignell, C F ^a   Luster, M I ^c  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e Gillette Research Institute   (United States)

Author keywords

Anthralin; Chemokines; Inflammation; Keratinocyte

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; CHEMOKINE; CYTOKINE; DITHRANOL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; NEUTRALIZING ANTIBODY; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOUREA DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFLAMMATION; KERATINOCYTE; PROMOTER REGION; RNA TRANSCRIPTION; SKIN TOXICITY;

ACETYLCYSTEINE; ADMINISTRATION, TOPICAL; ANTHRALIN; ANTI-INFLAMMATORY AGENTS; ANTIBODIES; ANTIOXIDANTS; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; KERATINOCYTES; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SUPEROXIDE DISMUTASE; THIOUREA; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN E;

EID: 0031942859     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050313     Document Type: Article

References (35)

1. Wiegrebe W, Muller K. Treatment of psoriasis with anthrones-chemical principles, biochemical aspects, and approaches to the design of novel derivatives. Skin Pharmacol 1995;8:1-24.
2. Kemeny L, Ruzicka T, Braun-Falco O. Dithranol: A review of the mechanism of action in the treatment of psoriasis vulgaris. Skin Pharmacol 1990;3:1-20.
3. Hayden PJ, Free KR, Chignell, CF. Structure-activity relationships for the formation of secondary radicals and inhibition of keratinocyte proliferation by 9-anthrones. Mol Pharmacol 1994; 46:186-98.
4. Schreck R, Baeuerle PA. A role for oxygen radicals as second messengers. Trends Cell Biol 1991;1:39-42.
5. Saran M, Bors W. Oxygen radicals acting as chemical messengers: A hypothesis. Free Radic Res Commun 1989;7:213-20.
6. Simconova PP, Luster MI. Asbestos induction of nuclear transcription factors and interleukin-8 gene regulation. Am J Respir Cell Mol Biol 1996;15:787-95.
7. Schreck R, Alberman K, Baeuerle PA. Nuclear factor κB: An oxidative stress-responsive transcription factor of eukaryotic cells. Free Radic Res Commun 1992;17:221-37.
8. Barker JNWN, Mitra RS, Griffiths CEM. Dixit VM, Nickoloff BJ. Keratinocytes as initiators of inflammation. Lancet 1991; 337:211-4.
9. Gottlieb AB, Chang CK, Posnett DN, Fanelli BJP. Detection of transforming growth factor α in normal, malignant and hyperproliferative human keratinocytes. J Exp Med 1988;167:670-5.
10. Matsue H. Cruz Jr PD, Bergstresser PR, Takashima A. Cytokine expression by epidermal cell subpopulations. J Invest Dermatol 1992;99:428-5.
11. Nakamura K, Williams IR, Kupper TS. Keratinocyle-derived monocyte chemoattractant protein 1 (MCP-1): Analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin. J Invest Dermatol 1995;105:635-43.
12. Kupper TS. Role of epidermal cytokines. In: Oppenheim J. Shevach EM. editors. Immunophysiology: Role of Cells and Cytokines in Immunity and Inflammation. New York: Oxford, 1990:285-305.
13. Wilmer JL, Burleson FG, Kayama F, Kanno J, Luster MI. Cytokine induction in human epidermal keratinocytes exposed to contact irritants and it's relation to chemical-induced inflammation in mouse skin. J Invest Dermatol 1994;102:915-22.
14. Yoshimura T, Matsushima K, Oppenheim JJ. Leonard EJ. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human peripheral blood mononuclear leukocytes: Partial characterization and separation from interleukin 1 (IL-1). J Immunol 1987;139:788-93.
15. Chabot-Fletcher M, Breton J, Lee J, Young P, Giswold DE. Interleukin-8 production is regulated by protein kinase C in human keratinocytes. J Invest Dermatol 1994;1032:509-15.
16. Venner TJ, Sander DN, Feliciani C, McKenzie RC. Interleukin-8 and melanoma growth-stimulating activity (GRO) are induced by ultraviolet B radiation in human keratinocyte cell lines. Exp Dermatol 1995;4:138-45.
17. Boyce ST, Ham RG, Cultivation, frozen storage and clonal growth of normal human epidermal keratinocytes in serum-free media. J Tiss Cult Meth 1985;9:83-93.
18. Kayama F, Yoshida T, Elwell MR, Luster MI. Role of tumor necrosis factor-α in cadmium-induced hepatotoxicity. Toxicol Appl Pharmacol 1995;131:224-34.
19. Flick DA, Gifford GE. Comparison of in vitro cell cytotoxicity assays for tumor necrosis factor. J Immunol Methods 1984;68: 167-75.
20. Oliveira IC, Mukaida N, Matsushima K, Vilcek J. Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-κB site. Mol Cell Biol 1994;14:5300-8.
21. Muller K, Wiegrebe W, Younes M. Dithranol, active oxygen species and lipid peroxidation in vivo. Arch Pharm (Weinheim) 1987;320:59-66.
22. Feng L, Xia Y, Garcia GE, Hwang D, Wilson CB. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis-α, and lipopolysaccharide. J Clin Invest 1995;95:1669-75.
23. Cerutti PA. Prooxidant states and tumor promotion. Science 1985;22:375-81.
24. Krebs A, Schaltegger H, Schaltegger A. Structure specificity of the antipsoriatic anthrones. Brit J Med 1981;105(S20):6-11.
25. Fuchs J, Milbrandt R, Zimmer G. Multifunctional analysis of the interaction of anthralin and it's metabolites anthraquinone and anthralin dimer with the inner mitochondrial membrane. Arch Dermatol Res 1990;282:47-55.
26. Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease: An overview. Meth Enzymol 1990; 186:1-85.
27. Halliwell B, Hoult JR, Blake DR. Oxidants, inflammation, and anti-inflammatory drugs. FASEB J 1988;2:2867-73.
28. Aruoma OI, Halliwell B. Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Rad Biol Med 1989;6:593-7.
29. Halliwell B. Free radicals and antioxidants: A personal view. Nutr Rev 1994;52:253-65.
30. DeForge LE, Fantone C, Kenney JS, Remick DG. Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood. J Clin Invest 1992;90:2123-9.
31. Eugui EM, DeLustro B, Rouhafza S, Ilnicka M, Lee SW, Wilhelm R, et al. Some antioxidants inhibit, in a coordinate fashion, the production of tumor necrosis factor-α, IL-β, and IL-6 by human peripheral blood mononuclear cells. Int Immunol 1994;6:409-22.
32. Larsen CG, Anderson AO, Oppenheim JJ, Matsushima K. Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumor necrosis factor. Immunology 1989;68:31-6.
33. Beg AA, Finco TS, Nantermet PV, Baldwin AS. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IkBa: A mechanism for NF-κB activation. Mol Cell Biol 1993;13:3301-10.
34. Kunsch C, Lang RK, Rosen CA. Shannon MF. Synergistic transcriptional activation of the IL-8 gene by NF-κB p65 (RelA) and NF-IL-6. J Immunol 1994;153:153-64.
35. DeForge LE, Preston AM, Takeuchi E, Kenney J, Boxer LA, Remick DG. Regulation of interleukin 8 gene expression by oxidant stress. J Biol Chem 1993;268:25568-76.